Oncogenic K-Ras Turns Death Receptors Into Metastasis-Promoting Receptors in Human and Mouse Colorectal Cancer Cells

Gastroenterology

Volumn 138, Issue 7, 2010, Pages 2357-2367

  Hoogwater, Frederik J H ^a   Nijkamp, Maarten W ^a   Smakman, Niels ^a   Steller, Ernst J A ^a   Emmink, Benjamin L ^a   Westendorp, B Florien ^a   Raats, Danielle A E ^a   Sprick, Martin R ^b   Schaefer, Uta ^c   Van Houdt, Winan J ^a   De Bruijn, Menno T ^a   Schackmann, Ron C J ^a   Derksen, Patrick W B ^a   Medema, Jan Paul ^b   Walczak, Henning ^d   Borel Rinkes, Inne H M ^a   Kranenburg, Onno ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

CD95; Colorectal; K Ras; Metastasis; TRAIL

Indexed keywords

COFILIN; DEATH RECEPTOR; FAS ANTIGEN; FAS LIGAND; GREEN FLUORESCENT PROTEIN; K RAS PROTEIN; LIM KINASE; LUCIFERASE; RAF PROTEIN; RHO KINASE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CELL SURVIVAL; COLORECTAL CANCER; CONTROLLED STUDY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LIVER CARCINOGENESIS; LIVER METASTASIS; METASTASIS INHIBITION; METASTASIS POTENTIAL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

EID: 77952829835     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2010.02.046     Document Type: Article

References (42)

1. Sjoblom T., Jones S., Wood L.D., et al. The consensus coding sequences of human breast and colorectal cancers. Science 314 (2006) 268-274
2. Wood L.D., Parsons D.W., Jones S., et al. The genomic landscapes of human breast and colorectal cancers. Science 318 (2007) 1108-1113
3. Jones S., Chen W.D., Parmigiani G., et al. Comparative lesion sequencing provides insights into tumor evolution. Proc Natl Acad Sci U S A 105 (2008) 4283-4288
4. Smakman N., Borel Rinkes I., Voest E.E., et al. Control of colorectal metastasis formation by K-Ras. Biochim Biophys Acta 1756 (2005) 103-114
5. Koshkina N.V., Khanna C., Mendoza A., et al. Fas-negative osteosarcoma tumor cells are selected during metastasis to the lungs: the role of the Fas pathway in the metastatic process of osteosarcoma. Mol Cancer Res 5 (2007) 991-999
6. Smyth M.J., Cretney E., Takeda K., et al. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon gamma-dependent natural killer cell protection from tumor metastasis. J Exp Med 193 (2001) 661-670
7. Takeda K., Hayakawa Y., Smyth M.J., et al. Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells. Nat Med 7 (2001) 94-100
8. Yang D., Stewart T.J., Smith K.K., et al. Downregulation of IFN-gammaR in association with loss of Fas function is linked to tumor progression. Int J Cancer 122 (2008) 350-362
9. Papenfuss K., Cordier S.M., and Walczak H. Death receptors as targets for anti-cancer therapy. J Cell Mol Med 12 (2008) 2566-2585
10. Barnhart B.C., Legembre P., Pietras E., et al. CD95 ligand induces motility and invasiveness of apoptosis-resistant tumor cells. EMBO J 23 (2004) 3175-3185
11. Trauzold A., Roder C., Sipos B., et al. CD95 and TRAF2 promote invasiveness of pancreatic cancer cells. FASEB J 19 (2005) 620-622
12. Trauzold A., Siegmund D., Schniewind B., et al. TRAIL promotes metastasis of human pancreatic ductal adenocarcinoma. Oncogene 25 (2006) 7434-7439
13. Kleber S., Sancho-Martinez I., Wiestler B., et al. Yes and PI3K bind CD95 to signal invasion of glioblastoma. Cancer Cell 13 (2008) 235-248
14. Peter M.E., Legembre P., and Barnhart B.C. Does CD95 have tumor promoting activities?. Biochim Biophys Acta 1755 (2005) 25-36
15. Peter M.E., Budd R.C., Desbarats J., et al. The CD95 receptor: apoptosis revisited. Cell 129 (2007) 447-450
16. Smakman N., Veenendaal L.M., van Diest P., et al. Dual effect of Kras(D12) knockdown on tumorigenesis: increased immune-mediated tumor clearance and abrogation of tumor malignancy. Oncogene 24 (2005) 8338-8342
17. Shirasawa S., Furuse M., Yokoyama N., et al. Altered growth of human colon cancer cell lines disrupted at activated Ki-ras. Science 260 (1993) 85-88
18. Smakman N., Martens A., Kranenburg O., et al. Validation of bioluminescence imaging of colorectal liver metastases in the mouse. J Surg Res 122 (2004) 225-230
19. Medema J.P., Scaffidi C., Kischkel F.C., et al. FLICE is activated by association with the CD95 death-inducing signaling complex (DISC). EMBO J 16 (1997) 2794-2804
20. Sprick M.R., Weigand M.A., Rieser E., et al. FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2. Immunity 12 (2000) 599-609
21. Lee K.H., Feig C., Tchikov V., et al. The role of receptor internalization in CD95 signaling. EMBO J 25 (2006) 1009-1023
22. Piazzolla D., Meissl K., Kucerova L., et al. Raf-1 sets the threshold of Fas sensitivity by modulating Rok-alpha signaling. J Cell Biol 171 (2005) 1013-1022
23. Bennett M.W., O'Connell J., Houston A., et al. Fas ligand upregulation is an early event in colonic carcinogenesis. J Clin Pathol 54 (2001) 598-604
24. Houston A., Waldron-Lynch F.D., Bennett M.W., et al. Fas ligand expressed in colon cancer is not associated with increased apoptosis of tumor cells in vivo. Int J Cancer 107 (2003) 209-214
25. Koornstra J.J., Kleibeuker J.H., van Geelen C.M., et al. Expression of TRAIL (TNF-related apoptosis-inducing ligand) and its receptors in normal colonic mucosa, adenomas, and carcinomas. J Pathol 200 (2003) 327-335
26. Mann B., Gratchev A., Bohm C., et al. FasL is more frequently expressed in liver metastases of colorectal cancer than in matched primary carcinomas. Br J Cancer 79 (1999) 1262-1269
27. O'Connell J., Bennett M.W., O'Sullivan G.C., et al. Fas ligand expression in primary colon adenocarcinomas: evidence that the Fas counterattack is a prevalent mechanism of immune evasion in human colon cancer. J Pathol 186 (1998) 240-246
28. Strater J., Hinz U., Walczak H., et al. Expression of TRAIL and TRAIL receptors in colon carcinoma: TRAIL-R1 is an independent prognostic parameter. Clin Cancer Res 8 (2002) 3734-3740
29. van Geelen C.M., Westra J.L., de Vries E.G., et al. Prognostic significance of tumor necrosis factor-related apoptosis-inducing ligand and its receptors in adjuvantly treated stage III colon cancer patients. J Clin Oncol 24 (2006) 4998-5004
30. Yoong K.F., Afford S.C., Randhawa S., et al. Fas/Fas ligand interaction in human colorectal hepatic metastases: a mechanism of hepatocyte destruction to facilitate local tumor invasion. Am J Pathol 154 (1999) 693-703
31. Nozoe T., Yasuda M., Honda M., et al. Fas ligand expression is correlated with metastasis in colorectal carcinoma. Oncology 65 (2003) 83-88
32. Li H., Fan X., Stoicov C., et al. Human and mouse colon cancer utilizes CD95 signaling for local growth and metastatic spread to liver. Gastroenterology 137 (2009) 934-944
33. Liu K., McDuffie E., and Abrams S.I. Exposure of human primary colon carcinoma cells to anti-Fas interactions influences the emergence of pre-existing Fas-resistant metastatic subpopulations. J Immunol 171 (2003) 4164-4174
34. Bos J.L. Ras oncogenes in human cancer: a review. Cancer Res 49 (1989) 4682-4689
35. Huser M., Luckett J., Chiloeches A., et al. MEK kinase activity is not necessary for Raf-1 function. EMBO J 20 (2001) 1940-1951
36. Mikula M., Schreiber M., Husak Z., et al. Embryonic lethality and fetal liver apoptosis in mice lacking the c-raf-1 gene. EMBO J 20 (2001) 1952-1962
37. Niault T., and Baccarini M. Targets of Raf in tumorigenesis. Carcinogenesis (2010) [Epub ahead of press]
38. Pritchard C.A., Bolin L., Slattery R., et al. Post-natal lethality and neurological and gastrointestinal defects in mice with targeted disruption of the A-Raf protein kinase gene. Curr Biol 6 (1996) 614-617
39. Chen J., Fujii K., Zhang L., et al. Raf-1 promotes cell survival by antagonizing apoptosis signal-regulating kinase 1 through a MEK-ERK independent mechanism. Proc Natl Acad Sci U S A 98 (2001) 7783-7788
40. O'Neill E., Rushworth L., Baccarini M., et al. Role of the kinase MST2 in suppression of apoptosis by the proto-oncogene product Raf-1. Science 306 (2004) 2267-2270
41. Wang W., Eddy R., and Condeelis J. The cofilin pathway in breast cancer invasion and metastasis. Nat Rev Cancer 7 (2007) 429-440
42. Scott R.W., and Olson M.F. LIM kinases: function, regulation and association with human disease. J Mol Med 85 (2007) 555-568